Clinical Trial Update: A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and pharmacokinetics of CRN04894 for Cushing's syndrome and related ACTH-dependent conditions is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Disease
• Cushing Syndrome
• Ectopic Acth Syndrome

Drugs mentioned

• CRN04894

Snippet

Sponsor: Crinetics Pharmaceuticals Inc. | Conditions: Cushing Syndrome, Cushing Disease | Phase 1, Phase 2 | Status: RECRUITING